The "Yondelis - API Insight, 2018" report has been added to ResearchAndMarkets.com's offering.
This report provides product and API manufacturers' details across US, Europe, China and India for Yondelis. It includes Yondelis overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities.
It further provides Yondelis`s patents information (US & EU). It also features the historical and forecasted sales of Yondelis till 2020. The report also highlights Yondelis`s market competition and emerging therapies which are in the same space as Yondelis.
Scope
- A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
- Patent information around Yondelis in United States (US) and Europe (EU) has been highlighted
- API manufacturers for Yondelis in United States, Europe, China and India
- The report contains historical and forecasted sales for Yondelis till 2020
- Enlists the market competition and emerging therapies in the space where Yondelis operates
Key Topics Covered
- Report Introduction
- Yondelis Overview
- Product Development Activities
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Safety and Efficacy of Yondelis
- Clinical Trial Description
- Other Pipeline Activities
- Adverse Reactions
- Dosage and Administration
- Product Description
- Product Details
- United States
- Europe
- Japan
- Yondelis Global Sales Assessment
- Historical Global Sales
- Forecasted Global Sales
- Yondelis Sales Region-wise
- Patent Details
- Global API Manufacturers
- United States
- India
- China
- Market Competitors
- Competitive Landscape (Emerging Therapies)
For more information about this report visit https://www.researchandmarkets.com/research/7tpnqb/yondelis_2018?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180720005115/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Oncology
Drugs , Software
Design and Development